Early detection of contrast-associated acute kidney injury after coronary angiography: A predictive value of osteopontin

Table 2 Laboratory findings in both groups of patients based on acute kidney injury

Variables	CA-AKI (n = 20)	Non-CA-AKI (n = 135)	P value
Blood count
Hb (g/dL)	11.25 ± 1.97	11.16 ± 1.26	0.349
Leucocytes (103/μL)	9.86 ± 4.57	7.75 ± 5.43	0.098
Platelets (103/μL)	209.05 ± 74.13	192.94 ± 98.51	0.238
Kidney function tests
Serum creatinine (mg/dL)	1.12 ± 0.09	1.09 ± 0.10	0.176
Urea (mg)	9.24 ± 2.17	8.18 ± 6.89	0.582
eGFR (mL/minute/1.73 m2)	99.84 ± 3.41	97.77 ± 2.65	0.092
Liver function tests and markers
ALT (U/L)	22.28 ± 6.11	25.70 ± 8.01	0.251
AST (U/L)	23.46 ± 8.85	26.23 ± 9.15	0.972
Bilirubin (mg/dL)	0.71 ± 0.04	0.78 ± 0.02	0.221
Albumin (g/dL)	3.78 ± 0.48	3.80 ± 0.49	0.923
Positive HCV antibodies	0	2 (1.5)	0.542
Positive HBsAg	1 (5.0)	1 (0.8)	0.813
Glycosylated Hb (%)	8.38 ± 0.98	6.45 ± 0.72	0.010
Lipid profile
Cholesterol (mg/dL)	197.60 ± 37.16	171.93 ± 29.28	0.563
HDL (mg/dL)	45.64 ± 12.21	54.32 ± 15.89	0.432
LDL (mg/dL)	103.79 ± 34.78	95.13 ± 24.38	0.670
Triglyceride (mg/dL)	152.39 ± 54.46	144.36 ± 35.40	0.581
Cardiac markers
Troponin (ng/mL)	8.11 ± 2.22	7.46 ± 3.30	0.762
Creatine kinase (U/L)	568.98 ± 123.78	501.23 ± 189	0.112
CK-MB (ng/mL)	15.55 ± 2.19	14.90 ± 3.19	0.118

Data are presented as mean ± SD or n (%). eGFR: Estimated glomerular filtration rate; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; HCV: Hepatitis C virus; HBsAg: Hepatitis B virus surface antigen; Hb: Hemoglobin; HDL: High-density lipoprotein; LDL: Low-density lipoprotein; CK-MB: Creatine kinase MB; CA-AKI: Contrast-associated acute kidney injury.